Global burden of gastric cancer attributable to Helicobacter pylori
- PMID: 24889903
- DOI: 10.1002/ijc.28999
Global burden of gastric cancer attributable to Helicobacter pylori
Abstract
We previously estimated that 660,000 cases of cancer in the year 2008 were attributable to the bacterium Helicobacter pylori (H. pylori), corresponding to 5.2% of the 12.7 million total cancer cases that occurred worldwide. In recent years, evidence has accumulated that immunoblot (western blot) is more sensitive for detection of anti-H. pylori antibodies than ELISA, the detection method used in our previous analysis. The purpose of this short report is to update the attributable fraction (AF) estimate for H. pylori after briefly reviewing new evidence, and to reassess the global burden of cancer attributable to H. pylori. We therefore reviewed the literature for studies comparing the risk of developing non-cardia gastric cancer (NCGC) in cases and controls, using both ELISA and multiple antigen immunoblot for detection of H. pylori. The results from prospective studies were combined, and the new pooled estimates were applied to the calculation of the AF for H. pylori in NCGC, then to the burden of infection-related cancers worldwide. Using the immunoblot-based data, the worldwide AF for H. pylori in NCGC increased from 74.7% to 89.0%. This implies approximately 120,000 additional cases of NCGC attributable to H. pylori infection for a total of around 780,000 cases (6.2% instead of 5.2% of all cancers). These updated estimates reinforce the role of H. pylori as a major cause of cancer.
Keywords: Helicobacter pylori; attributable fraction; gastric cancer; immunoblot.
© 2014 UICC.
Similar articles
-
A systematic review and meta-analysis on the relative and attributable risk of Helicobacter pylori infection and cardia and non-cardia gastric cancer.Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1251-1261. doi: 10.1080/14737159.2023.2277377. Epub 2023 Dec 15. Expert Rev Mol Diagn. 2023. PMID: 37905778 Review.
-
Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.Int J Epidemiol. 2023 Aug 2;52(4):1197-1208. doi: 10.1093/ije/dyad007. Int J Epidemiol. 2023. PMID: 36913255 Free PMC article.
-
Cardia and non-cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta-analysis, and estimation of population attributable fraction.Helicobacter. 2023 Apr;28(2):e12950. doi: 10.1111/hel.12950. Epub 2023 Jan 16. Helicobacter. 2023. PMID: 36645649 Review.
-
"True" Helicobacter pylori infection and non-cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project.Helicobacter. 2022 Jun;27(3):e12883. doi: 10.1111/hel.12883. Epub 2022 Mar 2. Helicobacter. 2022. PMID: 35235224
-
The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study.Lancet Public Health. 2021 Dec;6(12):e888-e896. doi: 10.1016/S2468-2667(21)00164-X. Lancet Public Health. 2021. PMID: 34838195 Free PMC article.
Cited by
-
Development of an Artificial Intelligence Model for the Classification of Gastric Carcinoma Stages Using Pathology Slides.Cureus. 2024 Mar 22;16(3):e56740. doi: 10.7759/cureus.56740. eCollection 2024 Mar. Cureus. 2024. PMID: 38650818 Free PMC article.
-
RSPO3 induced by Helicobacter pylori extracts promotes gastric cancer stem cell properties through the GNG7/β-catenin signaling pathway.Cancer Med. 2024 Apr;13(7):e7092. doi: 10.1002/cam4.7092. Cancer Med. 2024. PMID: 38581123 Free PMC article.
-
Differential cytokine expression in gastric tissues highlights helicobacter pylori's role in gastritis.Sci Rep. 2024 Apr 1;14(1):7683. doi: 10.1038/s41598-024-58407-x. Sci Rep. 2024. PMID: 38561502 Free PMC article.
-
Attitudes and Practices Regarding Helicobacter Pylori Infection Among the Public in Jordan: A Cross-Sectional Survey.Cureus. 2024 Feb 27;16(2):e55018. doi: 10.7759/cureus.55018. eCollection 2024 Feb. Cureus. 2024. PMID: 38550406 Free PMC article.
-
Research progress of metal-organic framework nanozymes in bacterial sensing, detection, and treatment.RSC Med Chem. 2023 Dec 1;15(2):380-398. doi: 10.1039/d3md00581j. eCollection 2024 Feb 21. RSC Med Chem. 2023. PMID: 38389881 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical